Application of prunella vulgaris alcohol extract in medicine for resisting nervous necrosis virus of fish

Susumulin extract is used to resist fish nerve necrosis viruses. By inhibiting virus replication and activating immune status, it solves the antiviral problems in fish farming, provides efficient and safe solutions, replaces antibiotics, and promotes high-quality ecology. Breeding.

CN118903248APending Publication Date: 2024-11-08GUANGXI FUQUN SEAWATER SEEDLING PROPAGATION CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411095506.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The lack of effective anti-fish neuronecrosis virus drugs in the prior art has caused serious impact on the fish farming industry, and the use of antibiotics has led to drug resistance and drug residues, affecting the aquatic ecology and consumer health.

Method used

The use of sausumulol extract as a drug to resist fish nerve necrosis viruses, provides safe and efficient prevention and treatment effects by significantly inhibiting viral replication, activating host cell immune status and inhibiting vertical infection, replacing traditional antibiotics and meeting environmental protection requirements.

Benefits of technology

Sugar subtilis extract significantly inhibits fish nerve necrosis virus, improves fish fry's disease resistance, reduces economic losses, promotes high-quality ecological breeding, reduces drug side effects, and provides green and safe antiviral solutions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903248A_ABST
    Figure CN118903248A_ABST
Patent Text Reader

Abstract

The invention particularly discloses application of a selfheal alcohol extract in a medicine for resisting nervous necrosis viruses of fishes. The application of the selfheal alcohol extract in the medicine for resisting the nervous necrosis virus of the fish has the advantages of improving the prevention and treatment effects on the nervous necrosis virus of the fish, reducing the drug resistance of the fish and generating toxic and side effects on the fish body due to prevention and treatment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of aquatic animal disease prevention and treatment, in particular to application of a self-pollinated alcohol extract in a drug for resisting fish neuronecrosis virus. Background Art

[0002] Fish Nervous Necrosis Virus infects more than 120 species of fish, including grouper and ovate pomfret. It is a highly contagious and pathogenic fish virus, which poses a serious threat to the development of aquaculture. However, there is currently no commercially available drug that is effective against fish Nervous Necrosis Virus, which has restricted the healthy development of aquaculture such as grouper and ovate pomfret. Therefore, it is urgent to develop a specific drug against fish Nervous Necrosis Virus.

[0003] In recent years, searching for antiviral ingredients from natural active ingredients of medicinal plants has become a research hotspot for developing new antiviral drugs at home and abroad. my country has rich medicinal plant resources and a long history of use. Mining antiviral active drugs from medicinal plants has broad application prospects.

[0004] Medicinal plants contain a variety of active ingredients, among which flavonoids, saponins, terpenoids, polysaccharides, alkaloids and other ingredients have multiple biological functions. In recent years, searching for natural active ingredients with antiviral effects from medicinal plants has become a new idea for the research and development of new plant-based drugs at home and abroad. my country is rich in medicinal plant resources, and the application prospects of exploring new plant-based drugs against aquatic animal viruses from medicinal plants are extremely broad. In-depth and systematic research on the role and mechanism of medicinal plants in viral infections of aquatic animals will help develop antiviral preparations of medicinal plants for aquatic use, effectively solve food safety problems such as drug resistance and drug residues caused by chemical drugs such as antibiotics, and is also an important development direction for achieving high-quality and healthy aquaculture. Summary of the invention

[0005] In order to solve the problems existing in the prior art, the present invention provides an application of an alcohol extract of Prunella vulgaris in a drug for resisting fish neuronecrosis virus.

[0006] In a first aspect, the present invention provides an application of an alcohol extract of Prunella vulgaris in a drug for resisting fish neuronecrosis virus, using the following technical solution:

[0007] Application of an alcohol extract of Prunella vulgaris in a drug for resisting fish neuronecrosis virus.

[0008] As a traditional Chinese medicine, Prunella vulgaris has a history of more than a thousand years of use in China. The New Compendium of Materia Medica calls it a holy medicine for treating ulcers. The whole plant is used as medicine, which has the effects of clearing the liver and purging fire, improving eyesight, dispersing nodules and reducing swelling. Pharmacological studies have found that Prunella vulgaris has multiple pharmacological effects such as anti-inflammatory, anti-tumor, antioxidant, antihypertensive, hypoglycemic, and immune regulation. It has a good effect on multi-system diseases such as cardiovascular and cerebrovascular diseases, immune system, and tumors. Prunella vulgaris contains active substances such as flavonoids and phenols, which have a certain inhibitory effect on bacterial and viral infections.

[0009] However, there are few reports on the application of Prunella vulgaris in the fight against fish neuronecrosis virus. On the one hand, based on the pharmacological effects disclosed in existing studies, Prunella vulgaris is widely used in anti-inflammatory, antioxidant, hypoglycemic, tumor and other aspects. Therefore, most of the current studies on Prunella vulgaris focus on these aspects. On the other hand, there is no targeted plant-based drug for the prevention or treatment of fish neuronecrosis virus.

[0010] The fish nervous necrosis virus will have a crucial impact on the healthy development of the fish farming industry. After the fish nervous necrosis virus breaks out in the fish school, it will cause large-scale fish deaths, which will not only cause huge economic losses to the breeders, but also the outbreak of the virus will have a negative impact on the aquatic ecological environment of the farmed fish. In addition, since the virus is not sensitive to antibiotics, antibiotics are generally used for prevention, and the use of antibiotics will also bring certain drug resistance to fish schools. In the subsequent application process, the dosage of antibiotics needs to be increased, resulting in a larger and larger dosage of antibiotics, which increases the burden on the fish liver, and the residual antibiotics in the fish will also pose a potential risk to the health of consumers. Therefore, how to prevent and control the infection and outbreak of fish nervous necrosis virus is of great significance to the healthy breeding of fish.

[0011] The present invention has found through a series of experimental studies that the alcohol extract of Prunella vulgaris can play a significant preventive and therapeutic role on fish nervous necrosis virus. Specifically, the alcohol extract of Prunella vulgaris can significantly inhibit the replication of fish nervous necrosis virus in cells, and has little cytotoxicity. Through research, it is found that the alcohol extract of Prunella vulgaris can not only directly act on fish nervous necrosis virus to exert an antiviral effect, but also activate the antiviral immune state of host cells before viral infection to cope with subsequent viral infection, and can also act on cells after viral infection to inhibit further viral infection. In addition, the alcohol extract of Prunella vulgaris also shows a strong effect on the inhibitory effect of vertical infection of fish nervous necrosis virus; after using the alcohol extract of Prunella vulgaris, the eggs laid by the parent fish infected with nervous necrosis virus have a higher concentration of anti-nervous necrosis virus antibodies, which helps to improve the ability of fry to resist nervous necrosis virus and improve the survival rate of fry.

[0012] In summary, the Herba Prunellae alcohol extract provided by the present invention can safely and efficiently prevent and treat fish neural necrosis virus, and meets environmental protection requirements, can reduce the economic losses caused by fish neural necrosis virus infection, and has an important role in promoting the high-quality ecological breeding of aquaculture industries such as grouper and ovate pomfret. Considering that Herba Prunellae has the effects of clearing liver and purging fire, improving eyesight, dispersing knots and reducing swelling, its biological toxicity is very small, therefore, it can be recommended for the prevention and treatment of fish neural necrosis virus. In addition, Herba Prunellae alcohol extract can specifically play a safe and efficient antiviral effect against fish neural necrosis virus, can be used as a green and safe fishery medicine to replace antibiotics, promote the high-quality ecological breeding of grouper, ovate pomfret, etc., and bring considerable economic benefits.

[0013] In a second aspect, the present invention provides an anti-fish neuronecrosis virus drug, which adopts the following technical solution:

[0014] A drug for resisting fish neuronecrosis virus, comprising ethanol extract of Prunella vulgaris.

[0015] The present application utilizes the alcohol extract of Prunella vulgaris to prepare drugs against fish nervous necrosis virus, which not only prepares drugs against fish nervous necrosis virus from a new perspective, but also shows through relevant experimental verification that the alcohol extract of Prunella vulgaris can safely and efficiently prevent and treat fish nervous necrosis virus, and meets the requirements of green, pollution-free and sustainable development, can promote high-quality ecological breeding in the aquaculture industry, and bring considerable economic benefits.

[0016] Preferably, the Prunella Vulgaris ethanol extract is prepared by a method comprising the following steps:

[0017] S1, mixing the herbaceous earth powder with petroleum ether, performing a first ultrasonic operation under heating conditions, performing solid-liquid separation after the first ultrasonic operation, further mixing the obtained solid matter with petroleum ether, and performing a second ultrasonic operation under heating conditions to obtain a pretreated solid product;

[0018] S2, mixing the pretreated solid product with methanol, performing a third ultrasonic operation under heating conditions, performing solid-liquid separation after the third ultrasonic operation, further mixing the obtained solid material with methanol, performing a fourth ultrasonic operation under heating conditions, and continuing solid-liquid separation to obtain a pretreated liquid product;

[0019] S3, distilling the pretreated liquid product under reduced pressure to obtain the Prunella Vulgaris ethanol extract.

[0020] Preferably, in S1, every 1g of the Prunella Vulgaris powder is mixed with 10-15mL of petroleum ether for 0.8-1.2h; the first ultrasonic operation is specifically 2-4 ultrasonic operations within 1h, each ultrasonic operation lasts for 4-6min, and the temperature during the ultrasonic operation is maintained at 56-65°C; the volume of petroleum ether added in the second mixing is the same as that added in the first mixing;

[0021] In S2, the volume of methanol is the same as the volume of petroleum ether added in the second mixing in S1; the mixing time is 0.7-1.2 hours; the second ultrasonic operation is specifically 2-4 times within 1 hour, each ultrasonication lasts for 4-6 minutes, and the temperature during the ultrasonication is 58-62°C; the volume of methanol added in the second mixing is the same as the volume of methanol added in the first mixing;

[0022] In S3, the temperature during the reduced pressure distillation is 58-62°C.

[0023] Preferably, the dosage form of the drug includes tablets, capsules, granules, pastes, liquids, pills or suspensions.

[0024] In a third aspect, the present invention provides a method for using an anti-fish neuronecrosis virus drug, using the following technical solution:

[0025] A method for using a drug for resisting fish neural necrosis virus comprises the following steps:

[0026] Using the selfheal ethanol extract to prepare a selfheal ethanol extract solution, and using the selfheal ethanol extract solution to prevent or treat fish neural necrosis virus;

[0027] In the Prunella vulgaris ethanol extract solution, the concentration of the Prunella vulgaris ethanol extract is 12.5 mg / mL-50 mg / mL.

[0028] Preferably, dimethyl sulfoxide is used to dissolve the alcohol extract of Prunella vulgaris to prepare a 100 mg / mL mother solution, which is then diluted with a cell culture medium to obtain the alcohol extract solution of Prunella vulgaris.

[0029] When using the alcohol extract of Prunella vulgaris to treat fish nervous necrosis viral diseases, the concentration of the alcohol extract of Prunella vulgaris will affect the therapeutic effect of fish nervous necrosis viral diseases. Specifically, when the alcohol extract of Prunella vulgaris is controlled within a suitable low range, it can significantly play its preventive role in fish nervous necrosis viral diseases, thereby greatly improving the resistance of fish that are not infected with fish nervous necrosis virus to fish nervous necrosis virus, and greatly reducing the risk of fish being infected with fish nervous necrosis virus; and when the alcohol extract of Prunella vulgaris is controlled within a suitable high range, it can have a good therapeutic effect on fish that have been infected with fish nervous necrosis virus, and minimize the vertical infection of fish nervous necrosis virus in fish, reduce the probability of fish that have been infected with fish nervous necrosis virus continuing to hatch unhealthy fry, and improve the survival rate of fry. In addition, when the concentration of Prunella vulgaris ethanol extract is too low, it will not be able to effectively play its preventive and therapeutic role on fish neuronecrosis virus. If the concentration of Prunella vulgaris ethanol extract is too high, although it will play its due therapeutic effect, it will also be accompanied by certain drug side effects, which will be detrimental to the healthy breeding of fish.

[0030] Preferably, when there is no fish nervous necrosis virus in the fish, the anti-fish nervous necrosis virus drug is used to prevent fish viral diseases, and the concentration of the Prunella vulgaris ethanol extract is 12.5 mg / mL-15 mg / mL;

[0031] When the fish contains the fish nervous necrosis virus, the anti-fish nervous necrosis virus drug is used to treat the fish viral disease, and the concentration of the Prunella vulgaris ethanol extract is 15 mg / mL-50 mg / mL. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 The biotoxicity of ethanol extract of Prunella vulgaris on spleen cells of grouper.

[0033] Figure 2 The figure shows the inhibitory effect of different concentrations of Prunella vulgaris ethanol extract on fish neuronecrosis virus (drug and virus co-incubated).

[0034] Figure 3 The inhibitory effect of Prunella Vulgaris ethanol extract on fish neuronecrosis virus (co-incubation of drug and virus).

[0035] Figure 4 The inhibitory effect of Prunella vulgaris ethanol extract on fish neuronecrosis virus (first treat the cells with drugs, then add viruses to infect the cells).

[0036] Figure 5 The figure shows the inhibitory effect of different concentrations of Prunella vulgaris on fish neuronecrosis virus (first infect the cells with the virus, and then treat the virus-infected cells with drugs). DETAILED DESCRIPTION

[0037] For better understanding and implementation, the technical solution of the present invention will be clearly and completely described below in conjunction with embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments.

[0038] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention herein are only for the purpose of describing specific embodiments and are not intended to limit the present invention.

[0039] Unless otherwise indicated, all numerical values ​​expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as modified by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth herein are approximations that can vary depending upon the desired properties desired to be obtained.

[0040] As used herein, "and / or" means one or all of the mentioned elements.

[0041] As used herein, “including” and “comprising” encompasses the case where only the stated elements are present as well as the case where there are other elements other than the stated elements.

[0042] All percentages in the present invention are by weight, unless otherwise specified.

[0043] Unless otherwise indicated, "a", "an", "an" and "the" used in this specification are intended to include "at least one" or "one or more". For example, "a component" means one or more components, so more than one component may be considered and may be employed or used in the implementation of the embodiment.

[0044] The quantitative experimental data involved in the following examples are expressed as mean ± standard deviation (±s), and the inter-group comparison data were statistically processed using SPSS 17.0 statistical software using the one-way horizontal variance analysis method.

[0045] The golden pomfret spleen cell line (Trachinotus ovatus spleen cells, TOSP) was established and stored in the applicant's laboratory and is available to the public from the applicant for use only in repeating the experiments of the present invention.

[0046] The fish nervous necrosis virus (NNV) was isolated from diseased grouper in Beihai, Guangxi, and stored in the applicant's laboratory. The public can obtain it from the applicant and it is only used to repeat the experiments of the present invention.

[0047] Prunella vulgaris: purchased from Yixin Pharmacy in Nanning, Guangxi (origin: Shiyan, Hubei).

[0048] Primers for coat protein (CP) gene of neuronecrosis virus: forward primer (qCP-F) 5'-CAACTGACAACGATCACACCTTC-3', reverse primer (qCP-R) 5'-CAATCGAACACTCCAGCGACA-3'. Primers for internal reference gene β-actin: forward primer (β-actin-F) 5'-TACGAGCTGCCTGACGGACA-3', reverse primer (β-actin-R) 5'-GGCTGTGATCTCCTTCTGCA-3'. Primers were synthesized by Shanghai Bioengineering.

[0049] The ethanol extract of Prunella vulgaris in the following examples was prepared by the following method:

[0050] S1, crushing 25g of Prunella vulgaris to obtain Prunella vulgaris powder, mixing the Prunella vulgaris powder with 250mL of petroleum ether, soaking for 1h, and then ultrasonically treating 3 times at 60°C within 1h, each ultrasonic treatment time being 5min, filtering out the petroleum ether after the ultrasonic treatment to obtain a solid product; further mixing the solid product with 250mL of petroleum ether, soaking for 1h, repeating the above operation of ultrasonic treatment, and filtering out the petroleum ether to obtain a pretreated solid product;

[0051] S2, mixing the pretreated solid product with 250 mL of methanol, and then performing ultrasonic treatment three times at 60° C. within 1 hour, each ultrasonic treatment lasting 5 minutes, and filtering out the liquid (for standby) after the ultrasonic treatment is completed to obtain a solid substance; further mixing the above solid substance with 250 mL of methanol, and filtering out the liquid after repeating the above ultrasonic operation to obtain a pretreated liquid product;

[0052] S3, placing the pretreated liquid product in a rotary evaporator, distilling it under reduced pressure at 60°C to a paste, and drying the paste product in a 55°C constant temperature drying oven to constant weight to obtain a selfheal ethanol extract; the selfheal ethanol extract is stored in a refrigerator at -20°C for later use.

[0053] Example 1

[0054] 1. Main instruments and reagents

[0055] Optical microscope, microplate reader, 5-(2,4-disulfophenyl)-3-(2-methoxy-4-nitrophenyl)-2H-tetrazolium sodium inner salt solution (WST-8 solution).

[0056] 2. Experimental Methods

[0057] TOSP cells were cultured at a rate of 1×10 5The number of cells / well was transferred into a 96-well plate, cultured at 28°C for 24 hours, and then the alcohol extract of Prunella vulgaris was diluted with cell culture medium to a concentration of 50 mg / mL; the experimental group was to add the alcohol extract of Prunella vulgaris to a 96-well plate and co-incubate with FHM cells (short for fathead mullet muscle cell line) at 28°C for 24 hours, 48 ​​hours and 72 hours, and then observe the changes in cell morphology under an optical microscope. After the optical microscopy observation, 20 μL of WST-8 solution was added to the cells in each well and continued to be cultured at 28°C for 4 hours, and then the absorbance at 450nm was detected by an enzyme marker. The cell survival rate is calculated as follows:

[0058] Cell survival rate = OD450 of experimental group / OD450 of control group × 100%.

[0059] 3. Experimental results

[0060] The results of cell microscopy observation were as follows Figure 1 As shown in A, there was no significant difference between the experimental group and the control group when the alcohol extract of Prunella vulgaris (Test group) was added for 24h, 48h and 72h. In addition, the cell survival rate results are shown in Figure 1 As shown in B, when the alcohol extract of Prunella vulgaris used in the experiment acted on FHM cells, the survival rate of FHM cells exceeded 95%, and there was no significant cytotoxic effect compared with the control group.

[0061] Example 2

[0062] 1. Main instruments and reagents

[0063] Real-time fluorescence quantitative PCR technology (qRT-PCR).

[0064] 2. Experimental Methods

[0065] TOSP cells were cultured at a rate of 8×10 5 The number of cells / well was accessed to a 12-well plate, cultured at 28°C for 24h, and then the alcohol extract of Prunella vulgaris was diluted with cell culture medium to 50mg / mL, 25mg / mL, and 12.5mg / mL. Three different concentrations of alcohol extract of Prunella vulgaris were co-incubated with NNV virus at 4°C for 2h and added to the cells in the 12-well plate and cultured at 28°C for 48h. The morphological changes of the cells in the experimental group and the control group were observed by optical microscopy, and then the cells in each group were collected and total RNA was extracted respectively. After RNA was reverse transcribed into cDNA, cDNA was used as a template, and β-actin gene was used as an internal reference gene. The expression of NNV virus CP gene was detected by RT-qPCR method to determine the inhibitory effect of the alcohol extract of Prunella vulgaris of this embodiment on NNV virus. The control group of the experiment was TOSP cells infected with NNV virus alone.

[0066] 3. Experimental results

[0067] The results of optical microscopy observations are as follows Figure 2 A shows that the pathological effect of the experimental group cells added with NNV and different concentrations of Prunella vulgaris ethanol extract was lower than that of the control group TOSP cells infected with NNV virus alone. In addition, the results of RT-qPCR detection of NNVCP gene expression are shown in Figure 2 As shown in B, the expression level of NNVCP gene in the experimental group cells to which NNV and different concentrations of Prunella vulgaris ethanol extract were added simultaneously was significantly lower than that in the control group TOSP cells infected with NNV virus only, and with the increase of the concentration of Prunella vulgaris ethanol extract, the inhibitory effect of NNV became more significant, indicating that Prunella vulgaris ethanol extract can inhibit the infection of NNV virus in cells in a concentration-dependent manner.

[0068] Example 3

[0069] 1. Main instruments and reagents

[0070] Real-time fluorescence quantitative PCR technology (qRT-PCR).

[0071] 2. Experimental Methods

[0072] In order to verify that the alcohol extract of Prunella vulgaris in Example 2 can directly interact with NNV virus particles, we used 1×10 6 TOSP cells with a concentration of 100 μL / mL were inoculated into 12-well culture plates at 800 μL per well and cultured in a constant temperature incubator at 28°C for 18 hours. Then, 20 μL of NNV virus was incubated with 50 mg / mL of Prunella vulgaris ethanol extract at 4°C for 2 hours, and then centrifuged at 25,000 × g at 4°C for 1.5 hours, the supernatant was discarded, and the NNV virus particles obtained by centrifugation were resuspended and mixed with 100 μL TN buffer; the control group was incubated with NNV virus and L15 culture medium, collected by centrifugation and resuspended. Then the old culture medium of TOSP cells in the 12-well plate was discarded, 800 μL of fresh culture medium was added, and 20 μL of resuspended NNV was added to TOSP cells, and infected at 28°C for 48 hours. Cell samples from each well were collected, total RNA was extracted, and RT-qPCR was performed to detect the expression of NNV virus CP gene. Three replicates were set for each group of samples.

[0073] 3. Experimental results

[0074] The results of fluorescence quantification showed that compared with TOSP cells to which NNV virus particles not treated with Prunella vulgaris alcohol extract were added (NNV group), the relative expression of NNV virus CP gene in TOSP cells (Test group) after incubation of Prunella vulgaris alcohol extract and NNV virus particles for 2 hours significantly decreased. This may be due to the possible change in the structure of NNV virus particles treated with Prunella vulgaris alcohol extract, resulting in reduced viral infectivity, which led to significantly lower expression of NNV virus CP gene in Prunella vulgaris alcohol extract-treated cells than in the NNV-infected group not treated with Prunella vulgaris alcohol extract. Figure 3 As shown, it is shown that the ethanol extract of Prunella vulgaris can directly interact with NNV virus particles to exert an antiviral effect.

[0075] Example 4

[0076] 1. Main instruments and reagents

[0077] Real-time fluorescence quantitative PCR technology (qRT-PCR).

[0078] 2. Experimental Methods

[0079] TOSP cells were cultured at a rate of 8×10 5 The number of cells / well was accessed to a 12-well plate, cultured at 28°C for 24h, and then the alcohol extract of Prunella vulgaris was diluted to 50mg / mL with cell culture medium and incubated with TOSP cells at 28°C for 2h, and the supernatant was discarded, and NNV virus-infected cells were added, and cultured at 28°C for 48h, and each group of cells was collected and total RNA was extracted, and the RNA was reverse transcribed into cDNA and cDNA was used as a template, and the β-actin gene was used as an internal reference gene. The expression of the NNV virus CP gene was detected by RT-qPCR to determine the inhibitory effect of the alcohol extract of Prunella vulgaris in this embodiment on the NNV virus. The control group of this experiment was TOSP cells that were not treated with the alcohol extract of Prunella vulgaris and only infected with NNV virus were added.

[0080] 3. Experimental results

[0081] The results of RT-qPCR detection of NNV virus CP gene expression are as follows Figure 4 As shown, the expression level of CP gene in TOSP cells (Test group) that were first treated with Prunella vulgaris ethanol extract and then infected with NNV virus was significantly lower than that in the control group TOSP cells (NNV group) that were not treated with Prunella vulgaris ethanol extract and only infected with NNV virus. This shows that pretreatment of TOSP cells with Prunella vulgaris ethanol extract may have activated the antiviral state of the cells and exerted antiviral function. Therefore, Prunella vulgaris ethanol extract can be used as a preventive drug for NNV virus to prevent NNV virus from infecting cells.

[0082] Example 5

[0083] 1. Main instruments and reagents

[0084] Real-time fluorescence quantitative PCR technology (qRT-PCR).

[0085] 2. Experimental Methods

[0086] TOSP cells were cultured at a rate of 8×10 5 The number of cells / well was accessed to a 12-well plate, cultured at 28°C for 24h, then NNV virus was added to each well cell to infect TOSP cells at 28°C for 2h, and the supernatant was discarded, and 50mg / mL of Prunella vulgaris ethanol extract was added to TOSP cells infected with NNV virus and cultured at 28°C for 48h, and then the cells of each group were collected and total RNA was extracted, which was reverse transcribed into cDNA and used as a template, β-actin gene as an internal reference gene, and the expression of NNV virus CP gene was detected by RT-qPCR method to determine the inhibitory effect of Prunella vulgaris ethanol extract of this embodiment on NNV virus. The control group of this experiment was TOSP cells that were not treated with Prunella vulgaris ethanol extract and only NNV virus was added.

[0087] 3. Experimental results

[0088] The results of RT-qPCR detection of NNV virus CP gene expression are as follows Figure 5 As shown, the expression level of NNV virus CP gene in TOSP cells treated with NNV virus first and then with Prunella vulgaris ethanol extract was significantly lower than that in the control group TOSP cells that were not treated with Prunella vulgaris ethanol extract and only infected with NNV virus, indicating that Prunella vulgaris ethanol extract can inhibit further infection of NNV virus after treating NNV virus-infected cells, indicating that Prunella vulgaris ethanol extract can treat cells infected with NNV virus.

[0089] The above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit the protection scope of the present invention. Although the present invention is described in detail with reference to the above embodiments, ordinary technicians in the relevant field should understand that the technical solutions of the present invention can be modified or equivalently replaced, but these modifications or replacements are all within the protection scope of the present invention.

Claims

1. Application of an alcohol extract of Prunella vulgaris in a drug for resisting fish neuronecrosis virus.

2. A drug for resisting fish neural necrosis virus, characterized in that: Including alcohol extract of Prunella Vulgaris.

3. The anti-fish neural necrosis virus drug according to claim 2, characterized in that: The Prunella Vulgaris ethanol extract is prepared by a method comprising the following steps: S1, mixing the herbaceous earth powder with petroleum ether, performing a first ultrasonic operation under heating conditions, performing solid-liquid separation after the first ultrasonic operation, further mixing the obtained solid matter with petroleum ether, and performing a second ultrasonic operation under heating conditions to obtain a pretreated solid product; S2, mixing the pretreated solid product with methanol, performing a third ultrasonic operation under heating conditions, performing solid-liquid separation after the third ultrasonic operation, further mixing the obtained solid material with methanol, performing a fourth ultrasonic operation under heating conditions, and continuing solid-liquid separation to obtain a pretreated liquid product; S3, distilling the pretreated liquid product under reduced pressure to obtain the Prunella Vulgaris ethanol extract.

4. The anti-fish neural necrosis virus drug according to claim 2, characterized in that: The dosage form of the drug includes tablets, capsules, granules, pastes, liquids, pills or suspensions.

5. A method for using a drug for resisting fish neural necrosis virus, characterized in that: The steps include: Using the selfheal ethanol extract to prepare a selfheal ethanol extract solution, and using the selfheal ethanol extract solution to prevent or treat fish neural necrosis virus; In the Prunella vulgaris ethanol extract solution, the concentration of the Prunella vulgaris ethanol extract is 12.5 mg / mL-50 mg / mL.

6. The method for using the anti-fish nerve necrosis virus drug as claimed in claim 5, characterized in that: When there is no fish nervous necrosis virus in the fish, the anti-fish nervous necrosis virus drug is used to prevent fish viral diseases, and the concentration of the Prunella vulgaris ethanol extract is 12.5 mg / mL-15 mg / mL; When the fish contains the fish nervous necrosis virus, the anti-fish nervous necrosis virus drug is used to treat the fish viral disease, and the concentration of the Prunella vulgaris ethanol extract is 15 mg / mL-50 mg / mL.

Citation Information

Patent Citations

  • Spica Prunellae injection for animals and preparation method thereof

    CN102552393A